Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
13.09B | 12.87B | 13.67B | 14.43B | 16.27B | 17.73B | Gross Profit |
2.46B | 0.00 | 3.09B | 3.18B | 3.58B | 3.64B | EBIT |
532.00M | 0.00 | 466.00M | -659.00M | 1.60B | -397.00M | EBITDA |
1.61B | 2.17B | 1.81B | 942.00M | 3.17B | 3.07B | Net Income Common Stockholders |
-75.00M | 389.00M | 91.00M | -566.00M | 718.00M | -146.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.72B | 1.80B | 1.22B | 1.86B | 2.67B | 2.97B | Total Assets |
13.03B | 13.21B | 13.87B | 15.85B | 20.14B | 22.04B | Total Debt |
4.50B | 1.55B | 4.87B | 5.37B | 6.17B | 6.97B | Net Debt |
2.78B | -245.00M | 3.64B | 3.51B | 3.50B | 4.00B | Total Liabilities |
9.78B | 9.71B | 10.80B | 12.03B | 14.76B | 16.73B | Stockholders Equity |
2.99B | 3.23B | 2.81B | 3.82B | 5.38B | 5.31B |
Cash Flow | Free Cash Flow | ||||
838.00M | 1.15B | 954.00M | 960.00M | 952.00M | -391.00M | Operating Cash Flow |
1.36B | 1.40B | 1.36B | 1.42B | 1.50B | 124.00M | Investing Cash Flow |
-467.00M | -512.00M | -491.00M | -635.00M | -60.00M | 4.67B | Financing Cash Flow |
-867.00M | -317.00M | -1.49B | -1.51B | -1.82B | -5.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $7.73B | 15.04 | 22.21% | 1.42% | 7.31% | -15.86% | |
74 Outperform | $3.59B | 14.08 | 6.34% | 2.31% | 21.67% | -17.91% | |
72 Outperform | $2.60B | 14.41 | 21.21% | ― | -0.64% | 30.96% | |
66 Neutral | $2.48B | 16.15 | 8.65% | ― | -8.05% | -18.60% | |
60 Neutral | $11.59B | 10.39 | -7.23% | 2.94% | 7.46% | -10.76% | |
52 Neutral | $9.41B | 39.12 | 12.09% | ― | -8.20% | ― | |
46 Neutral | $2.77B | 7.25 | 12.88% | ― | -5.65% | 78.20% |